8PCU | pdb_00008pcu

Structure of serine-beta-lactamase CTX-M-14 following the time-resolved active site binding of boric acid and subsequent glycerol-boric acid-ester formation, 5000 ms


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.50 Å
  • R-Value Free: 
    0.163 (Depositor) 
  • R-Value Work: 
    0.141 (Depositor) 
  • R-Value Observed: 
    0.142 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8PCU

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Time-resolved crystallography of boric acid binding to the active site serine of the beta-lactamase CTX-M-14 and subsequent 1,2-diol esterification.

Prester, A.Perbandt, M.Galchenkova, M.Oberthuer, D.Werner, N.Henkel, A.Maracke, J.Yefanov, O.Hakanpaa, J.Pompidor, G.Meyer, J.Chapman, H.Aepfelbacher, M.Hinrichs, W.Rohde, H.Betzel, C.

(2024) Commun Chem 7: 152-152

  • DOI: https://doi.org/10.1038/s42004-024-01236-w
  • Primary Citation Related Structures: 
    8PC9, 8PCA, 8PCB, 8PCC, 8PCD, 8PCE, 8PCF, 8PCG, 8PCI, 8PCJ, 8PCK, 8PCL, 8PCM, 8PCN, 8PCO, 8PCP, 8PCQ, 8PCR, 8PCS, 8PCT, 8PCU, 8PCV, 8R7M

  • PubMed Abstract: 

    The emergence and spread of antibiotic resistance represent a growing threat to public health. Of particular concern is the appearance of β-lactamases, which are capable to hydrolyze and inactivate the most important class of antibiotics, the β-lactams. Effective β-lactamase inhibitors and mechanistic insights into their action are central in overcoming this type of resistance, and in this context boronate-based β-lactamase inhibitors were just recently approved to treat multidrug-resistant bacteria. Using boric acid as a simplified inhibitor model, time-resolved serial crystallography was employed to obtain mechanistic insights into binding to the active site serine of β-lactamase CTX-M-14, identifying a reaction time frame of 80-100 ms. In a next step, the subsequent 1,2-diol boric ester formation with glycerol in the active site was monitored proceeding in a time frame of 100-150 ms. Furthermore, the displacement of the crucial anion in the active site of the β-lactamase was verified as an essential part of the binding mechanism of substrates and inhibitors. In total, 22 datasets of β-lactamase intermediate complexes with high spatial resolution of 1.40-2.04 Å and high temporal resolution range of 50-10,000 ms were obtained, allowing a detailed analysis of the studied processes. Mechanistic details captured here contribute to the understanding of molecular processes and their time frames in enzymatic reactions. Moreover, we could demonstrate that time-resolved crystallography can serve as an additional tool for identifying and investigating enzymatic reactions.


  • Organizational Affiliation
    • Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf UKE, Hamburg, Germany.

Macromolecule Content 

  • Total Structure Weight: 28.29 kDa 
  • Atom Count: 2,297 
  • Modeled Residue Count: 261 
  • Deposited Residue Count: 263 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Beta-lactamase263Klebsiella pneumoniaeMutation(s): 0 
Gene Names: ctx-m-14
EC: 3.5.2.6
UniProt
Find proteins for A0A0H3H219 (Klebsiella pneumoniae subsp. pneumoniae (strain HS11286))
Explore A0A0H3H219 
Go to UniProtKB:  A0A0H3H219
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0A0H3H219
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.50 Å
  • R-Value Free:  0.163 (Depositor) 
  • R-Value Work:  0.141 (Depositor) 
  • R-Value Observed: 0.142 (Depositor) 
Space Group: P 32 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 41.84α = 90
b = 41.84β = 90
c = 233.28γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
CrystFELdata reduction
CrystFELdata scaling
PHENIXphasing
Cootmodel building

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Joachim Herz StiftungGermany--
German Federal Ministry for Education and ResearchGermany--
German Research Foundation (DFG)Germany--

Revision History  (Full details and data files)

  • Version 1.0: 2024-06-26
    Type: Initial release
  • Version 1.1: 2024-07-17
    Changes: Database references
  • Version 1.2: 2024-10-23
    Changes: Structure summary